XM does not provide services to residents of the United States of America.

Asia stocks weaken on the patient approach to rate cuts



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>GLOBAL MARKETS-Asia stocks weaken on the patient approach to rate cuts</title></head><body>

By Rae Wee

SINGAPORE, May 23 (Reuters) -Several key Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.

MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS lost 0.57%. Australia's S&P/ASX 200 index .AXJO was one of the biggest decliners, slumping 0.8%, also hurt by a pullback in some commodity prices.

Geopolitical tensions also kept investors nervous as China's military started two days of "punishment" drills held in five areas around Taiwan just days after new Taiwan President Lai Ching-te took office. But Taiwan's stock market .TWII was not too fussed and was last up 0.3%.

More hawkish-than-expected minutes of the Federal Reserve's latest policy meeting, a hot UK inflation print and a sobering assessment of New Zealand's inflation problems from the country's central bank have caused investors to pare their bets of the pace and scale of global rate cuts expected this year.

"One thing that's interesting from the last 24 hours that can be taken away is still the uncertainty from central banks about policy settings and at what levels interest rates have to be at, and where they need to potentially stay at, in order to tame inflation" said Kyle Rodda, senior financial market analyst at Capital.com.

"That's causing uncertainty from a policy point of view, but it's obviously also causing uncertainty from a market point of view."

U.S. futures meanwhile received an early boost after AI darling Nvidia NVDA.O forecast quarterly revenue above estimates after the bell on Wednesday, which sent its shares jumping 5.9% in extended trade. .N

S&P 500 futures ESc1 tacked on 0.3%, while Nasdaq futures NQc1 gained 0.57% in Asia trade.

Japan's Nikkei .N225 rose 0.6%, drawing some support from a weaker yen JPY=EBS that touched its lowest level in over three weeks. It was last at 156.85 per dollar.

Sterling GBP=D3 and the kiwi NZD=D3 held near two-month highs and last bought $1.2721 and $0.6102, respectively.

Data on Wednesday showed inflation in Britain eased less than expected and a key core measure of prices barely dropped, prompting investors to pull bets on a Bank of England rate cut next month. 0#BOEWATCH

Earlier that day, the Reserve Bank of New Zealand wrongfooted markets by warning cuts were unlikely until far into 2025 at the conclusion of its policy meeting where it held its cash rate steady as expected.

"There are still 'hard yards' to be done to bring annual CPI inflation down to the 2% target midpoint in a timely and sustainable manner, and thus monetary policy easing remains unlikely this year," said Kelly Eckhold, Westpac chief economist for New Zealand.

"Our baseline view remains that the first 25bp policy easing will occur in February next year, to be followed by a series of gradual (once a quarter) 25bp reductions that will eventually lower the OCR to around 3.75% in 2026."

Elsewhere in Asia, Hong Kong's Hang Seng Index .HSI ran into profit taking and fell 1.5%, after having touched an over nine-month high at the start of the week.

China's blue-chip index .CSI300 eased 0.3%.

Gold dipped 0.25% to $2,372.28 an ounce XAU=, away from its record high of $2,449.89 hit on Monday, as the prospect of higher-for-longer U.S. rates took some shine off the yellow metal. GOL/

Oil prices likewise fell, with brent crude LCOc1 down 0.82% to $81.23 a barrel, while U.S. crude CLc1 edged 0.9% lower to $76.87 per barrel. O/R



World FX rates YTD http://tmsnrt.rs/2egbfVh

Global asset performance http://tmsnrt.rs/2yaDPgn

Asian stock markets https://tmsnrt.rs/2zpUAr4


Reporting by Rae Wee; Editing by Edwina Gibbs

To read Reuters Markets and Finance news, click on https://www.reuters.com/finance/markets For the state of play of Asian stock markets please click on: 0#.INDEXA
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.